Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01492218
NCT01492218
Completed
Not Applicable

A Prospective, Open-labelled, Non-controlled Observational Study to Assess Patient Satisfaction, Physician Acceptability and Safety of Mixtard® 30 NovoLet® for the Treatment of Diabetes Mellitus

Novo Nordisk A/S1 site in 1 country1,330 target enrollmentMarch 15, 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventionsbiphasic human insulin 30
Drugsbiphasic human insulin 30

Overview

Phase
Not Applicable
Intervention
biphasic human insulin 30
Conditions
Diabetes
Sponsor
Novo Nordisk A/S
Enrollment
1330
Locations
1
Primary Endpoint
Change in Diabetes Treatment Satisfaction Questionnaire (DTSQ) score
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

This study is conducted in Asia. The aim of this study is to assess patient satisfaction after switching to biphasic human insulin 30 treatment using the NovoLet® insulin device as treatment for diabetes mellitus under normal clinical practice setting.

Registry
clinicaltrials.gov
Start Date
March 15, 2004
End Date
August 30, 2004
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Diabetes mellitus (type 1 or type 2)
  • •Patient not presently using Mixtard® 30 NovoLet®

Exclusion Criteria

  • Not provided

Arms & Interventions

NovoLet®

Intervention: biphasic human insulin 30

Outcomes

Primary Outcomes

Change in Diabetes Treatment Satisfaction Questionnaire (DTSQ) score

Secondary Outcomes

  • Adverse events
  • Technical complaints of NovoLet® device

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Long Term Observation of Patient Satisfaction Post INTRACOR Treatment Based on Patient Perception and Diagnostic DataPresbyopia
NCT01164358Technolas Perfect Vision GmbH105
Completed
Not Applicable
Vivity Insight: A Study of Patient Satisfaction and Visual PerformanceCataract
NCT04495049Research Insight LLC60
Completed
Phase 4
Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy ChangeRelapsing Remitting Multiple Sclerosis
NCT01317004Novartis Pharmaceuticals61
Recruiting
Not Applicable
Observational study to evalute patient satisfaction with different oral cannabis productsPatients (cannabis-naïve / cannabis-experienced) with a diagnosed disease for which medical cannabis is indicated in the sense of the Cannabis as Medicine (CAM) Act.
DRKS00032743Avextra Pharma GmbH500
Terminated
Phase 4
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic DrugSchizophrenia
NCT01592201Janssen Korea, Ltd., Korea13